🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.230
-0.120 (-5.11%)
Nov 20, 2026, 4:00 PM EST - Market closed

Sunshine Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
14.629.129.6916.2921.832.05
Short-Term Investments
0.42----0.01
Cash & Short-Term Investments
15.049.129.6916.2921.832.05
Cash Growth
61.63%-5.81%-40.55%-25.36%963.27%105.79%
Accounts Receivable
3.893.463.872.551.910.01
Receivables
3.893.463.872.551.910.01
Inventory
11.6613.4711.285.733.290.11
Prepaid Expenses
0.410.81.130.310.280.03
Total Current Assets
3126.8525.9724.8927.312.2
Property, Plant & Equipment
0.961.341.481.011.150.01
Other Intangible Assets
1.891.893.021.440.78-
Long-Term Deferred Tax Assets
--0.09---
Total Assets
33.8630.0830.5627.3529.242.2

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.335.665.542.592.80.04
Accrued Expenses
-----0.05
Current Portion of Leases
0.20.220.210.120.12-
Current Income Taxes Payable
0.270.270.270.30.37-
Other Current Liabilities
-0.30.32.553.63-
Total Current Liabilities
4.796.446.315.556.930.09
Long-Term Debt
-----1.9
Long-Term Leases
0.430.60.740.540.64-
Long-Term Deferred Tax Liabilities
---0.050.04-
Total Liabilities
5.227.047.066.147.621.99

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
00000.020
Additional Paid-In Capital
108.3198.193.3584.4280.8432.79
Retained Earnings
-79.05-75.02-69.04-63.91-59.4-32.66
Comprehensive Income & Other
-0.64-0.07-0.830.70.16-0.02
Total Common Equity
28.6223.0323.4921.2121.630.11
Shareholders' Equity
28.6423.0423.521.2121.630.21
Total Liabilities & Equity
33.8630.0830.5627.3529.242.2

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
0.630.810.950.660.771.9
Net Cash (Debt)
14.418.318.7315.6321.060.15
Net Cash Growth
70.55%-4.84%-44.14%-25.77%13687.37%-
Net Cash Per Share
119.63399.85----
Filing Date Shares Outstanding
0.820.020.01---
Total Common Shares Outstanding
0.280.020.01---
Working Capital
26.2120.4119.6519.3420.382.1
Book Value Per Share
102.85938.671820.76---
Tangible Book Value
26.7321.1420.4719.7620.850.11
Tangible Book Value Per Share
96.04861.641586.67---
Machinery
--0.790.540.48-
Leasehold Improvements
--0.090.02--
SEC Filings: 10-K · 10-Q